首页> 美国卫生研究院文献>Journal of Cancer >Lyn Kinase Promotes the Proliferation of Malignant Melanoma Cells through Inhibition of Apoptosis and Autophagy via the PI3K/Akt Signaling Pathway
【2h】

Lyn Kinase Promotes the Proliferation of Malignant Melanoma Cells through Inhibition of Apoptosis and Autophagy via the PI3K/Akt Signaling Pathway

机译:Lyn Kinase通过抑制细胞凋亡和自噬通过PI3K / Akt信号通路促进恶性黑色素瘤细胞的增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Melanoma is a malignant tumor of cutaneous melanocytes that is characterized by high grade malignancy, rapid progression and high mortality. Thus far, its specific etiological mechanism has been unclear. In this study, we discovered that Lyn kinase expression was up-regulated in melanoma tissues and cells. The function of Lyn was determined by knocking down its expression with a lentivirus containing Lyn shRNA and upregulating its expression with pcDNA3.1-Lyn in the melanoma cell lines M14 and A375. The results showed that Lyn knockdown could significantly inhibit the proliferation, migration and invasiveness through its inhibition of apoptosis and autophagy via the PI3K/Akt pathway in melanoma cell lines. This was further confirmed by treatment with PI3K inhibitor BEZ235. Up-regulation of Lyn promoted the expression of p-Akt and Cyclin D1. Additionally, we investigated the effects of Lyn inhibitor Bafetinib on melanoma cells and the results were consistent with Lyn knockdown. Collectively, our results indicated that Lyn plays a carcinogenic role in multiple cellular functions during melanoma development through regulating apoptosis and autophagy via the PI3K/Akt pathway and may be a valuable potential target for the clinical treatment of melanoma.
机译:黑色素瘤是皮肤黑素细胞的恶性肿瘤,其特征在于高度恶性,快速进展和高死亡率。迄今为止,其具体病因机制尚不清楚。在这项研究中,我们发现Lyn激酶表达在黑色素瘤组织和细胞中上调。 Lyn的功能是通过用含有Lyn shRNA的慢病毒敲低它的表达并用pcDNA3.1-Lyn上调其在黑素瘤细胞M14和A375中的表达来确定的。结果表明,Lyn敲除可以通过PI3K / Akt途径抑制黑素瘤细胞系的凋亡和自噬,从而显着抑制增殖,迁移和侵袭性。通过用PI3K抑制剂BEZ235治疗进一步证实了这一点。 Lyn的上调促进了p-Akt和Cyclin D1的表达。此外,我们研究了Lyn抑制剂Bafetinib对黑色素瘤细胞的作用,结果与Lyn击倒相一致。总体而言,我们的结果表明,Lyn通过调节细胞凋亡和PI3K / Akt途径自噬,在黑色素瘤发展过程中的多种细胞功能中发挥致癌作用,并且可能是黑色素瘤临床治疗的潜在潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号